These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1373216)

  • 1. Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetic tests.
    Nersessians AK
    Mutat Res; 1992 Apr; 281(4):239-43. PubMed ID: 1373216
    [No Abstract]   [Full Text] [Related]  

  • 2. The "rodent carcinogen" dilemma: formidable challenge for the technologies of the new millennium.
    Johnson FM
    Ann N Y Acad Sci; 2000; 919():288-99. PubMed ID: 11083119
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests.
    Shelby MD; Zeiger E
    Mutat Res; 1990; 234(3-4):257-61. PubMed ID: 2366790
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning rules to predict rodent carcinogenicity of non-genotoxic chemicals.
    Lee Y; Buchanan BG; Mattison DM; Klopman G; Rosenkranz HS
    Mutat Res; 1995 May; 328(2):127-49. PubMed ID: 7739598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical carcinogenicity: can it be predicted from knowledge of mutagenicity and allergic contact dermatitis?
    Rosenkranz HS; Karol MH
    Mutat Res; 1999 Dec; 431(1):81-91. PubMed ID: 10656488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rodent bone marrow micronucleus assay: contrast between its sensitivity to human carcinogens and its insensitivity to NTP rodent carcinogens.
    Ashby J; Tinwell H
    Mutat Res; 1996 Jun; 352(1-2):181-4. PubMed ID: 8676908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the NTP database to assess the value of rodent carcinogenicity studies for determining human cancer risk.
    Haseman JK
    Drug Metab Rev; 2000 May; 32(2):169-86. PubMed ID: 10774773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will all chemicals be carcinogenic to rodents when adequately evaluated?
    Ashby J; Purchase IF
    Mutagenesis; 1993 Nov; 8(6):489-93. PubMed ID: 8133777
    [No Abstract]   [Full Text] [Related]  

  • 12. Doses in rodent cancer studies: sorting fact from fiction.
    Bucher JR
    Drug Metab Rev; 2000 May; 32(2):153-63. PubMed ID: 10774772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard.
    Tennant RW
    Mutat Res; 1993 Mar; 286(1):111-8. PubMed ID: 7678907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rodent carcinogens: setting priorities.
    Gold LS; Slone TH; Stern BR; Manley NB; Ames BN
    Science; 1992 Oct; 258(5080):261-5. PubMed ID: 1411524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of rodent carcinogenesis bioassays.
    Ward JM
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):212. PubMed ID: 18029286
    [No Abstract]   [Full Text] [Related]  

  • 17. Society of toxicologic pathology position on assessment of hyperplastic lesions in rodent carcinogenicity studies.
    Boorman G; Dixon D; Elwell M; Kerlin R; Morton D; Peters T; Regan K; Sullivan J;
    Toxicol Pathol; 2004; 32(1):124-5. PubMed ID: 14713557
    [No Abstract]   [Full Text] [Related]  

  • 18. Mathematical parameters for quantification of mutational responses in bacteria.
    Roldán-Arjona T; Pueyo C; Haynes RH
    Mutat Res; 1995 Feb; 346(2):77-84. PubMed ID: 7885403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the predictivity of some short-term assays for carcinogenicity in rodents.
    Klopman G; Rosenkranz HS
    Mutat Res; 1991 Dec; 253(3):237-40. PubMed ID: 1720198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can rodent cancer tests predict for human cancers? Proceedings of a toxicology symposium. Little Rock, Arkansas, USA. November 12-13, 1998.
    Drug Metab Rev; 2000 May; 32(2):119-266. PubMed ID: 10950630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.